
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; EDTA; ethylenediaminetetraacetic acid; FTLD; frontotemporal lobar degeneration; GFAP; glial fibrillary acidic protein; HE; hematoxylin and eosin; HPRT; hypoxanthine phosphoribosyltransferase;